Securities Code: 002432 Securities Abbreviation: Nine-An Medical Announcement No.: 2026-008
Tianjin Nine-An Medical Electronics Co., Ltd. Announcement on Company's Participation in Subscription of Asset Unit Shares
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and that there are no false records, misleading statements, or material omissions.
Special Notice:
- Name of the investment target: Huangpu River Capital SPC XG Asset Unit (hereinafter referred to as "XG Asset Unit" or "XG Unit")
- Investment amount: The Company's wholly-owned subsidiary, Andon Hong Kong Co., Limited (hereinafter referred to as "Nine-An Hong Kong"), will participate in the subscription of the XG Asset Unit with its own funds of US$10 million, and simultaneously pay US$500,000 as a management service fee during the term, totaling approximately 0.35% of the Company's net assets as of the most recent audited period. Huangpu River Capital SPC, on behalf of the subscriber of the XG Asset Unit, subscribes for and holds shares of XG Technologies Holding Ltd. (hereinafter referred to as "XG TECH" or "the target company"). After this investment, Nine-An Hong Kong indirectly holds 61,764,908 shares of Series B preferred stock and other preferred stock of XG TECH, accounting for 0.9269% of the total share capital of XG TECH.
- This investment will not have a significant impact on the Company's current operating performance and financial indicators.
- This investment has no principal protection or minimum return commitment and is only invested in Series B preferred stock and other preferred stock of XG TECH. The investment target is susceptible to market changes in its industry, industry policy regulation, and other factors, which may affect the investment value of the asset unit and even lead to investment failure and loss risks. This investment has the characteristics of a long investment recovery period and low liquidity. The investment process may be affected by macroeconomic conditions, industry cycles, market competition, policy environment, and the operating management of the proposed investment projects, and there is a risk that the expected returns may not be realized after the investment. The Company will closely monitor the subsequent progress of this investment and fulfill its information disclosure obligations in a timely manner in accordance with relevant laws and regulations. We kindly remind investors to invest rationally and pay attention to investment risks.
- This investment does not constitute a related party transaction, nor does it constitute a major asset restructuring as stipulated in the "Measures for the Administration of Major Asset Restructuring of Listed Companies." In accordance with the "Shenzhen Stock Exchange Stock Listing Rules," "Company Articles of Association," and other relevant regulations, this matter does not require submission to the Company's Board of Directors and Shareholders' Meeting for deliberation.
I. Overview of External Investment